United States
Germany
Japan
United Kingdom
China
MCL1 (NM_021960) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC200521L3V
- LentiORF®
-
Lenti ORF particles, MCL1 (Myc-DDK tagged) - Human myeloid cell leukemia sequence 1 (BCL2-related) (MCL1), nuclear gene encoding mitochondrial protein, transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
Product images
CNY 1,999.00
CNY 2,700.00
CNY 2,950.00
Specifications
| Product Data | |
| Product Name | MCL1 (NM_021960) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | bcl2-L-3; BCL2L3; EAT; Mcl-1; MCL1-ES; mcl1/EAT; MCL1L; MCL1S; TM |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | NM_021960 |
| ORF Size | 1050 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC200521).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_021960.3 |
| RefSeq Size | 4020 bp |
| RefSeq ORF | 1053 bp |
| Locus ID | 4170 |
| Domains | Bcl-2 |
| Protein Families | Druggable Genome, Transmembrane |
| MW | 37.2 kDa |
| Gene Summary | This gene encodes an anti-apoptotic protein, which is a member of the Bcl-2 family. Alternative splicing results in multiple transcript variants. The longest gene product (isoform 1) enhances cell survival by inhibiting apoptosis while the alternatively spliced shorter gene products (isoform 2 and isoform 3) promote apoptosis and are death-inducing. [provided by RefSeq, Oct 2010] |
Documents
| Product Manuals |
| FAQs |
| SDS |
